162 related articles for article (PubMed ID: 34691728)
1. Using bio-orthogonally catalyzed lethality strategy to generate mitochondria-targeting anti-tumor metallodrugs
Xue X; Qian C; Tao Q; Dai Y; Lv M; Dong J; Su Z; Qian Y; Zhao J; Liu HK; Guo Z
Natl Sci Rev; 2021 Sep; 8(9):nwaa286. PubMed ID: 34691728
[TBL] [Abstract][Full Text] [Related]
2. Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents.
Lv M; Qian X; Li S; Gong J; Wang Q; Qian Y; Su Z; Xue X; Liu HK
J Inorg Biochem; 2023 Jan; 238():112057. PubMed ID: 36370504
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulation with chemotherapy of a ruthenium-arene complex via blockading CD47 signal in chronic myelogenous leukemia cells.
Hu G; Lv M; Guo B; Huang Y; Su Z; Qian Y; Xue X; Liu HK
J Inorg Biochem; 2023 Jun; 243():112195. PubMed ID: 36996696
[TBL] [Abstract][Full Text] [Related]
4. A New Strategy to Fight Metallodrug Resistance: Mitochondria-Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer Cells.
Wang MM; Xu FJ; Su Y; Geng Y; Qian XT; Xue XL; Kong YQ; Yu ZH; Liu HK; Su Z
Angew Chem Int Ed Engl; 2022 Jul; 61(27):e202203843. PubMed ID: 35384194
[TBL] [Abstract][Full Text] [Related]
5. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Effect of Organometallic Half-Sandwich Ru(II)-Arene Complexes Bearing a Glutathione
Han T; Wu Y; Han W; Yan K; Zhao J; Sun Y
Inorg Chem; 2021 Sep; 60(17):13051-13061. PubMed ID: 34369147
[TBL] [Abstract][Full Text] [Related]
7. Biocompatible Azide-Alkyne "Click" Reactions for Surface Decoration of Glyco-Engineered Cells.
Gutmann M; Memmel E; Braun AC; Seibel J; Meinel L; Lühmann T
Chembiochem; 2016 May; 17(9):866-75. PubMed ID: 26818821
[TBL] [Abstract][Full Text] [Related]
8. Homo- and Hetero-dinuclear Arene-Linked Osmium(II) and Ruthenium(II) Organometallics: Probing the Impact of Metal Variation on Reactivity and Biological Activity.
Wilson CS; Prior TJ; Sandland J; Savoie H; Boyle RW; Murray BS
Chemistry; 2020 Sep; 26(50):11593-11603. PubMed ID: 32520396
[TBL] [Abstract][Full Text] [Related]
9. Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol.
Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
Dalton Trans; 2019 Apr; 48(16):5352-5360. PubMed ID: 30942794
[TBL] [Abstract][Full Text] [Related]
10. In-situ Generated and Premade 1-Copper(I) Alkynes in Cycloadditions.
Wang X; Wang X; Wang X; Zhang J; Liu C; Hu Y
Chem Rec; 2017 Dec; 17(12):1231-1248. PubMed ID: 28639363
[TBL] [Abstract][Full Text] [Related]
11. From mechanism to mouse: a tale of two bioorthogonal reactions.
Sletten EM; Bertozzi CR
Acc Chem Res; 2011 Sep; 44(9):666-76. PubMed ID: 21838330
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-Targeting Anticancer Metal Complexes.
Erxleben A
Curr Med Chem; 2019; 26(4):694-728. PubMed ID: 29521200
[TBL] [Abstract][Full Text] [Related]
13. Interventional nuclear medicine: "click" chemistry as an
Welling MM; Duszenko N; van Willigen DM; Hensbergen AW; Buckle T; Rietbergen DDD; Roestenberg M; van Leeuwen FWB
Biomater Sci; 2021 Mar; 9(5):1683-1690. PubMed ID: 33410436
[TBL] [Abstract][Full Text] [Related]
14. Bio-orthogonal click-targeting nanocomposites for chemo-photothermal synergistic therapy in breast cancer.
Qiao J; Tian F; Deng Y; Shang Y; Chen S; Chang E; Yao J
Theranostics; 2020; 10(12):5305-5321. PubMed ID: 32373214
[TBL] [Abstract][Full Text] [Related]
15. Clickable, hydrophilic ligand for fac-[M(I)(CO)3](+) (M = Re/(99m)Tc) applied in an S-functionalized α-MSH peptide.
Kasten BB; Ma X; Liu H; Hayes TR; Barnes CL; Qi S; Cheng K; Bottorff SC; Slocumb WS; Wang J; Cheng Z; Benny PD
Bioconjug Chem; 2014 Mar; 25(3):579-92. PubMed ID: 24568284
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a pillar[5]arene-based [2]rotaxane with two equivalent stations via copper(I)-catalyzed alkyne-azide cycloaddition.
Ogoshi T; Iizuka R; Kotera D; Yamagishi TA
Org Lett; 2015 Jan; 17(2):350-3. PubMed ID: 25539029
[TBL] [Abstract][Full Text] [Related]
17. Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.
Chen H; Parkinson JA; Morris RE; Sadler PJ
J Am Chem Soc; 2003 Jan; 125(1):173-86. PubMed ID: 12515520
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective Copper Catalyzed Alkyne-Azide Cycloaddition by Dynamic Kinetic Resolution.
Liu EC; Topczewski JJ
J Am Chem Soc; 2019 Apr; 141(13):5135-5138. PubMed ID: 30888164
[TBL] [Abstract][Full Text] [Related]
19. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
[TBL] [Abstract][Full Text] [Related]
20. Unexpected Reactions of Terminal Alkynes in Targeted "Click Chemistry'' Coppercatalyzed Azide-alkyne Cycloadditions.
Ali TH; Heidelberg T; Hussen RSD; Tajuddin HA
Curr Org Synth; 2019; 16(8):1143-1148. PubMed ID: 31984920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
